Pharmaceutical research in paediatric populations and the new EU Paediatric Legislation: an industry perspective
<p>Abstract</p> <p>A large proportion of medicines used in children are prescribed off-label, and children have often been denied access to new or innovative medications. Because such situation is unethical, the need to obtain paediatric information for medicines used in children s...
Saved in:
Main Author: | Auby Philippe (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2008-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The european paediatric legislation: benefits and perspectives
by: Rocchi Francesca, et al.
Published: (2010) -
Prevention of Industrial Accidents in the EU Legislation
by: Dariusz Materniak
Published: (2018) -
Suitability of paediatric legislation beyond the USA and Europe: a qualitative study on access to paediatric medicines
by: Albrecht Jahn, et al.
Published: (2024) -
Pharmaceutical technological aspects and possibility of using transdermal patches in paediatric population
by: Đekić Ljiljana, et al.
Published: (2014) -
New Frontiers in Paediatric Neurology
by: Mubeen Fatima Rafay
Published: (2018)